Evidence map›Paper›PMID 39627218›Full record

ArticleNature communications2024

Epi-microRNA mediated metabolic reprogramming counteracts hypoxia to preserve affinity maturation.

Rinako Nakagawa, Miriam Llorian, Sunita Varsani-Brown, Probir Chakravarty, Jeannie M Camarillo, David Barry, Roger George, Neil P Blackledge, Graham Duddy, Neil L Kelleher and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. A guide to B cell metabolism.Nature reviews. Immunology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rinako NakagawaImmunity and Cancer Laboratory, Francis Crick Institute, London, UK. rinako.nakagawa@crick.ac.uk.ORCID 0000-0003-2511-0444
Miriam LlorianBioinformatics and Biostatistics Laboratory, Francis Crick Institute, London, UK.ORCID 0000-0003-2582-6602
Sunita Varsani-BrownGenetic Modification Service Laboratory, Francis Crick Institute, London, UK.
Probir ChakravartyBioinformatics and Biostatistics Laboratory, Francis Crick Institute, London, UK.
Jeannie M CamarilloDepartment of Chemistry, Molecular Biosciences and the National Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, IL, USA.
David BarryAdvanced Light Microscopy Laboratory, Francis Crick Institute, London, UK.
Roger GeorgeStructural Biology Laboratory, Francis Crick Institute, London, UK.
Neil P BlackledgeDepartment of Biochemistry, University of Oxford, Oxford, UK.
Graham DuddyGenetic Modification Service Laboratory, Francis Crick Institute, London, UK.
Neil L KelleherDepartment of Chemistry, Molecular Biosciences and the National Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, IL, USA.ORCID 0000-0002-8815-3372
Robert J KloseDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0002-8726-7888
Martin TurnerImmunology Programme, The Babraham Institute, Cambridge, UK.ORCID 0000-0002-3801-9896
Dinis P CaladoImmunity and Cancer Laboratory, Francis Crick Institute, London, UK. dinis.calado@crick.ac.uk.ORCID 0000-0001-8239-7184

Funding

TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
NIGMS NIH HHS P41 GM108569RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BBS/E/B/000C0407Wellcome Trust CC2078
6 · The paper itself

Abstract

To increase antibody affinity against pathogens, positively selected GC-B cells initiate cell division in the light zone (LZ) of germinal centers (GCs). Among these, higher-affinity clones migrate to the dark zone (DZ) and vigorously proliferate by utilizing energy provided by oxidative phosphorylation (OXPHOS). However, it remains unknown how positively selected GC-B cells adapt their metabolism for cell division in the glycolysis-dominant, cell cycle arrest-inducing, hypoxic LZ microenvironment. Here, we show that microRNA (miR)-155 mediates metabolic reprogramming during positive selection to protect high-affinity clones. Mechanistically, miR-155 regulates H3K36me2 levels in hypoxic conditions by directly repressing the histone lysine demethylase, Kdm2a, whose expression increases in response to hypoxia. The miR-155-Kdm2a interaction is crucial for enhancing OXPHOS through optimizing the expression of vital nuclear mitochondrial genes under hypoxia, thereby preventing excessive production of reactive oxygen species and subsequent apoptosis. Thus, miR-155-mediated epigenetic regulation promotes mitochondrial fitness in high-affinity GC-B cells, ensuring their expansion and consequently affinity maturation.

Indexed as

MicroRNAsOxidative PhosphorylationAnimalsB-LymphocytesCell HypoxiaCellular ReprogrammingEpigenesis, GeneticGerminal CenterGlycolysisHistonesHumansJumonji Domain-Containing Histone DemethylasesMetabolic ReprogrammingMiceMice, Inbred C57BLMitochondriaHistonesJumonji Domain-Containing Histone DemethylasesMicroRNAsMirn155 microRNA, mouseReactive Oxygen Species

Identifiers

PMID39627218
PMCPMC11615350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.